HOME COMPANY PROFILE MANAGEMENT INVESTOR RELATIONS OVERVIEW CORPORATE GOVERNANCE STOCK TRANSFER AGENT SEC FILINGS SECTION 16 FORMS PRESENTATIONS/EVENTS  PUBLICATIONS PRESS RELEASES ANNUAL REPORTS CONTACT   Publications   To view our documents, you must use PDF software. All documents are compatible with Adobe® v6.0 and higher. NasulinTM (Intranasal Recombinant Human Insulin) November 2, 2009 | 37 pages   Recent News   AUGUST 09, 2010 CPEX PHARMACEUTICALS REPORTS SECOND-QUARTER 2010 FINANCIAL RESULTS   MAY 26, 2010 CPEX PHARMACEUTICALS SHAREHOLDERS ELECT ROBERT FORRESTER TO BOARD OF DIRECTORS   MAY 06, 2010 CPEX PHARMACEUTICALS BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS SHAREHOLDERS REJECT TENDER OFFER ANNOUNCED BY RICHARD ROFÉ     P I P E L I N E   P A R T N E R I N G   F A C T   S H E E T

[ HOME | COMPANY PROFILE | MANAGEMENT | INVESTOR RELATIONS | CONTACT ]   CPEX PHARMACEUTICALS, INC. 2 HOLLAND WAY EXETER NH 03833 TEL: 603.658.6100 FAX: 603.658.6101